New study now opening to recruitment!

We are looking for healthy volunteers who want to be involved in a new study involving wearable technology and wearable devices, available from January 2022.

£250 fee paid

You can participate if you:

• Are aged between 18-48
• Are healthy, without active medical problems, including symptoms or exposure to COVID-19
• Take no regular medications
• Don’t smoke
• Don’t take illicit substances
• Meet our sleep health criteria
• Have a BMI (body mass index) between 18-25
• Are not currently or intending to become pregnant

Scan the QR code to enquire more and to get a copy of the Information Sheet!

email

grp-microdialysisprojects@groups.bristol.ac.uk

 

A long overdue update

The coronavirus pandemic has been extremely disruptive to our research. However we now finally have the microdialysis data available for all the pilot participants. We also have a pair of talented masters students working with Eder in Birmingham on on aspects of the data analysis.

Thomas will be presenting the the bioRHYTHM concept and some of the results at the upcoming online BSN-SNE meeting in September. He will also be continuing research with the bioRHYTHM system as part of a recently success Wellcome Trust grant in collaboration with the Professor Debra Skene (Surrey), researchers at the University of Cardiff, University Hospitals Bristol and Weston NHS Foundation Trust, and DesignWorks Windsor.

 

 

bioRHYTHM in the time of coronavirus

The coronavirus outbreak has caused widespread disruption to research including the bioRHYTHM studies. Luckily we had completed recruitment of 11 volunteers in the bioRHYTHM pilot trial. All hormone samples managed to make their way to Martijn’s lab in Groningen before the University of Bristol closed our lab!

What is happening now?

We are spending time reviewing and starting to analyse all the data from our participants. We have hormone profile results from the first 4 participants. Analysis of the rest of the samples will depend on when facilities in Groningen are able to return to normal research activities.

What is coming next?

We are very keen to apply our technology and dynamic measurement system in a clinical context. Watch this space…

 

Our team